The company provides development and manufacturing services to discovery companies, and partners with brand, virtual and specialty pharmaceutical companies to develop technology-based products that would have IP protection and/or market exclusivity.
The company owns multiple proprietary drug delivery technology platforms that provide practical solutions to challenging product development problems.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze